Mutations in either ClC-7, a late endosomal/lysosomal member of the CLC family of chloride channels and transporters, or in its ␤-subunit Ostm1 cause osteopetrosis and lysosomal storage disease in mice and humans. The severe phenotype of mice globally deleted for ClC-7 or Ostm1 and the absence of storage material in cultured cells hampered investigations of the mechanism leading to lysosomal pathology in the absence of functional ClC-7/Ostm1 transporters. Tissue-specific ClC-7-knockout mice now reveal that accumulation of storage material occurs cell-autonomously in neurons or renal proximal tubular cells lacking ClC-7. Almost all ClC-7-deficient neurons die. The activation of glia is restricted to brain regions where ClC-7 has been inactivated. The effect of ClC-7 disruption on lysosomal function was investigated in renal proximal tubular cells, which display high endocytotic activity. Pulse-chase endocytosis experiments in vivo with mice carrying chimeric deletion of ClC-7 in proximal tubules allowed a direct comparison of the handling of endocytosed protein between cells expressing or lacking ClC-7. Whereas protein was endocytosed similarly in cells of either genotype, its half-life increased significantly in ClC-7-deficient cells. These experiments demonstrate that lysosomal pathology is a cell-autonomous consequence of ClC-7 disruption and that ClC-7 is important for lysosomal protein degradation.-Wartosch, L., Fuhrmann, J. C., Schweizer, M., Stauber, T., Jentsch, T. J. Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC-7. FASEB J. 23, 000 -000 (2009). www.fasebj.org
Ϫ

/H
ϩ exchangers (1) . Of the 9 mammalian CLC proteins, 4 members are plasma membrane Cl Ϫ channels, whereas others, including ClC-7, are sited predominantly in membranes of the endolysosomal pathway (2) . The presence of a certain "proton glutamate" in ClC-3 through ClC-7 suggested that ClC-7 functions as a
Cl
Ϫ /H ϩ exchanger, in analogy to the bacterial EcClC-1 (3) and mammalian ClC-4 and ClC-5 proteins (4, 5) . Indeed lysosomes, which prominently express ClC-7 and its ␤-subunit Ostm1 (6-8), show Cl Ϫ /H ϩ -exchange activity (9) . ClC-7/Ostm1 is also found on late endosomes and a specialized acid-secreting plasma membrane domain of osteoclasts (6 -8) . The latter membrane ("ruffled border") is believed to be formed by lysosomal exocytosis.
Compartments of the endocytic pathway are progressively acidified along their way from the plasma membrane to the lysosome. Their low luminal pH is important for such processes as receptor-ligand interaction, endolysosomal trafficking, and luminal enzymatic activity (10) , rendering it a key parameter for processing and degradation of endocytosed material. The active accumulation of protons is achieved mainly through V-type H ϩ -ATPases that act as electrogenic proton pumps. Intracellular CLC proteins are thought to facilitate endosomal/lysosomal acidification by providing an electrical shunt for proton pumping (2) .
Disruption of specific vesicular CLC proteins has diverse effects, such as impaired renal endocytosis and kidney stone formation with a loss of ClC-5 (11) (12) (13) or neurodegeneration with the loss of ClC-3 (14) . The loss of either ClC-7 (7) or its ␤-subunit Ostm1 (8, 15) leads to excessive bone mineralization (osteopetrosis) and to a severe degeneration of the brain and retina (6 -8) . The neurodegeneration observed in mice lacking either ClC-7 or Ostm1 displays typical features of human neuronal ceroid lipofuscinosis (NCL), a neurodegenerative lysosomal storage disease (6, 8) . Neurological abnormalities and blindness have also been described in osteopetrotic patients carrying mutations in CLCN7 (16) or OSTM1 on both alleles (17) . In Clcn7 Ϫ/Ϫ mice, the accumulation of lysosomal storage material in neuronal cell bodies precedes neuronal cell loss that is evident as early as 30 d after birth (P30) (6) . The exact mechanism for lysosomal deposition with a loss of ClC-7/Ostm1 activity is unknown. Neither lysosomal pH nor the activity of the lysosomal enzyme tripeptidylpeptidase I (TPP I) were altered in cultured ClC-7-deficient neurons or fibroblasts (6) . The short life span and complex phenotype of constitutive ClC-7-knockout (KO) mice (6, 7) was a severe obstacle in the analysis of lysosomal function in vivo and prevented us from following the progression of neurodegeneration.
Newly generated conditional KO mice now reveal that accumulation of lysosomal storage material is intrinsic to cells lacking ClC-7. The massive activation of microglia and astrocytes is limited to brain regions where ClC-7 has been deleted. Chimeric deletion of ClC-7 in proximal tubular cells (PTCs) enabled us to compare directly the uptake and degradation of proteins between cells of either genotype. We show that ClC-7 is important for the lysosomal degradation of proteins but not for their endocytotic uptake.
MATERIALS AND METHODS
Mice
To generate "floxed" ClC-7 mice, a part of the murine ClC-7 gene (Clcn7), extending from the intron preceding exon 6 to the intron after exon 16, was cloned into a pKO Scrambler plasmid (Lexicon Genetics Incorporated, Woodland, TX, USA). A loxP site with a 5Ј EcoRI site was introduced in the intron upstream of exon 12, a neomycin resistance (neo) cassette flanked by loxP sites behind exon 13, and a diphtheria toxin A cassette at the 5Ј end of the targeting construct (Supplemental Fig. 1A ). The vector was electroporated into R1 embryonal stem cells, and clones were tested for homologous recombination by Southern blot analysis (Supplemental Fig. 1B ). After transfection with a plasmid expressing Cre recombinase, clones were tested for removal of the neo cassette by Southern blotting (Supplemental Fig. 1C ). C57BL/6 blastocysts injected with correctly targeted cells were implanted into foster mothers. Male chimeras were bred with C57BL/6 females to yield heterozygous floxed ClC-7 mice (Clcn7 ϩ/lox ). Forebrain-specific ClC-7-KO mice were obtained by crossing Clcn7 lox/lox mice with mice (in a mixed C57BL/6-129/ SVJ background) expressing Cre recombinase under control of the EMX1 promotor (18), mice with partial ClC-7 deletion in proximal tubules (PTs) by crossing Clcn7 lox/lox mice with ApoE-cre mice (19) and backcrossing into C57BL/6 for Ն5 generations. In all experiments, wild-type (WT; Clcn7
ϩ/lox ;cre, or Clcn7 ϩ/ϩ ;cre littermates served as controls.
Clcn7 Ϫ/Ϫ and Clcn5 Ϫ/Ϫ mice were described previously (7, 11) . Deleter-Cre mice (20) were provided by Ralf Kühn (Helmholtz Zentrum München, Munich, Germany), EMX1-Cre mice (18) by Takuji Iwasato and Shigeyoshi Itohara (Brain Science Institute, RIKEN, Saitama, Japan), and ApoE-Cre mice (19) by Thomas Willnow (MDC, Berlin, Germany). All experiments conformed to the animal protection laws of Germany.
Histology and immunohistochemistry
Primary antibodies used were own KO-controlled rabbit antiClC-7 (7), guinea-pig anti-ClC-7 (8), rabbit anti-Ostm1 (8), rabbit anti-ClC-5 (21), rabbit anti-ClC-3 (22) , mouse antilysobisphosphatidic acid (LBPA; ref. 23) , rat anti-lysosomeassociated membrane protein-1 (lamp-1; clone 1D4B; BD Pharmingen, Heidelberg, Germany), mouse anti-villin (Acris, Hiddenhausen, Germany), mouse anti-parvalbumin (Swant, Bellinzona, Switzerland), mouse anti-NeuN (Chemicon, Temeculla, CA, USA), rabbit anti-IBA1 (Wako Chemicals, Richmond, VA, USA), and mouse anti-glial fibrillary acidic protein (GFAP; Sigma, Deisenhofen, Germany). Secondary antibodies conjugated to Alexa Fluor 488, 546, or 633 (Molecular Probes, Karlsruhe, Germany) or horseradish peroxidase (HRP; Dianova, Hamburg, Germany) were used.
HRP was detected by incubation in solution containing 0.05% (w/v) 3,3Ј-diaminobenzidine (DAB), 0.03% (w/v) H 2 O 2 , and 0.04% nickel ammonium sulfate in 0.01 M phosphate buffer (PB). Endogenous peroxidase was exhausted by preincubation for 30 min in 0.3% H 2 O 2 in 0.1 M PB. GSA-biotin (Griffonia simplicifolia agglutinin; Vector Laboratories, Burlingame, CA, USA) was detected using StreptavidinCy3 (Molecular Probes, Karlsruhe, Germany).
Perfusion of deeply anesthetized mice, fixation, and preparation of tissue and staining procedures were performed as described previously (6) . For alkaline phosphatase-staining the Sigma Fast™ Fast Red TR/Naphtol AS-MX substrate kit (Sigma) was used according to the manufacturer's instructions.
Electron microscopy procedures were described previously (6) . For semithin sections, tissues were sliced to 0.7 m and stained with 0.1% (w/v) toluidine blue.
In vivo endocytosis of protein
Bovine ␤-lactoglobulin (L3908; Sigma) was labeled with either Alexa Fluor 546 or 700 succinimidyl esters (Molecular Probes). Dye solution in DMSO (50 l of 10 mg/ml) was mixed with 1 ml ␤-lactoglobulin in PBS (10 mg/ml) and incubated under stirring for 1.5 h at RT in the dark. Uncoupled dye was removed by passing through Sephadex™ G-25 PD10 (GE Healthcare, Freiburg, Germany).
Mice were injected with labeled ␤-lactoglobulin (5 g/g body weight for kidney-specific ClC-7-KO mice, 20 g/g for ClC-7/ClC-5 double-KO mice) or with HRP type VI (300 g/g) (Sigma) in PBS into the tail vein. Mice were anesthetized and perfused transcardially for 3 min using either PBS with 0.01% (w/v) heparin alone (for tissue lysates) or followed by 4% (w/v) PFA in PBS (immunohistochemistry).
Quantification of protein degradation
Mice were injected with ␤-lactoglobulin Alexa Fluor 546 and fixed as described above. After immunostaining kidney sections for ClC-7 and villin, images were acquired with an SP2 confocal microscope equipped with an ϫ40 1.25-NA oilimmersion lens (Leica, Mannheim, Germany). Imaging settings for the ␤-lactoglobulin Alexa Fluor 546 recording were identical for all tubules of the same time point. Fluorescence was quantified using the program NIH ImageJ 1.34 (http:// rsbweb.nih.gov/ij/). In a chimeric PT, a region of interest (ROI) was drawn around ClC-7-expressing and -deficient PT areas, respectively, including the villin-stained brush border. For each tubule, the fluorescence intensity of ␤-lactoglobulin Alexa Fluor 546 was measured for the same number of WT and ClC-7-KO ROIs and the mean intensity was calculated. ClC-7-KO cells, respectively. For each PT, the ratio of the corrected WT and ClC-7-KO ␤-lactoglobulin fluorescence was calculated. Three independent experiments were performed, and more than 20 chimeric PTs per time point and animal were analyzed. Statistical differences were calculated with a Student's t test for paired data.
SDS-PAGE and immunoblot
Tissue homogenate preparation and immunoblots were performed as described previously (6) . Equal amounts of protein were separated by SDS-PAGE using 4 -12% NuPage ® gradient bis-Tris gels in NuPage MES buffer (Invitrogen, Karlsruhe, Germany). ␤-lactoglobulin Alexa Fluor 700 was detected using a LI-COR ® Odyssey fluorescent reader (LI-COR Biosciences, Bad Homburg, Germany) at 680-nm excitation and 780-nm emission wavelengths. For immunoblots, anti-␣-tubulin, anti-actin (both Sigma), anti-LC3 (AP1802a; Abgent, San Diego, CA, USA), anti-ClC-7 (7), anti-ClC-3 (22) , anti-ClC-5 (11), anti-Lamp-1 (BD Pharmingen) primary antibodies, and HRP-conjugated secondary antibodies (Dianova) were used.
RESULTS
Neurodegeneration in mice with forebrain-specific ClC-7 deletion
To inactivate ClC-7 in a tissue-specific manner, we generated mice in which exons 12 and 13 of the Clcn7 gene are flanked by loxP sites (Supplemental Fig. 1 ). Mice homozygous for the floxed Clcn7 allele exhibited normal levels of the ClC-7 protein (Supplemental Fig.  2A ) and did not display any obvious phenotype regarding size, weight, or bone density (Supplemental Fig.  2B ). Cre-mediated excision of Clcn7 exons 12 and 13 leads to a premature stop codon in exon 14, within helix I of the trans-membrane domain. A truncated amino-terminal portion of ClC-7 could not be detected (data not shown), owed to either nonsense-mediated RNA decay or protein instability. Ubiquitous deletion of the floxed Clcn7 allele by crossing Clcn7 lox/lox mice with the deleter strain (20) produced the same phenotype as the constitutive ClC-7 KO (7), including severe osteopetrosis (Supplemental Fig. 2C ).
We first crossed floxed ClC-7 mice with the EMX1-cre strain (18) . This strain expresses Cre recombinase mainly in the hippocampus and cortical structures of the forebrain (18) , as confirmed by reporter gene analysis (Fig. 1A) . The forebrain-restricted ClC-7 deletion was visualized by the reduction of ClC-7 immunoreactivity in the cortex and hippocampus (Fig. 1B , C and Supplemental Fig. 3A) . In other brain regions, e.g., the cerebellum, ClC-7 levels appeared unchanged ( Fig.  1C and Supplemental Fig. 3C ). ClC-7 deletion in cortex and hippocampus was incomplete because parvalbumin-positive, inhibitory neurons of the cortex and hippocampus still expressed ClC-7 (Supplemental Fig.  3B ). This finding agrees with the predominant expression of Cre recombinase in excitatory neurons of the forebrain in EMX1-cre mice (18) .
Forebrain-specific ClC-7-KO mice lived to the same age as WT littermates. They neither differed in size nor showed any sign of osteopetrosis (data not shown). Neurological abnormalities such as hind-limb clasping became apparent at the age of 4 -5 mo (data not shown). At the same time, KO mice displayed a drastic reduction of the cortex ( Fig. 1D-I ). Nissl-stained sagittal brain sections revealed a massive loss of cortical neurons ( Fig. 1E, H) . In contrast, regions in which ClC-7 was not deleted (such as the cerebellum) were spared from neurodegeneration. Additionally, an enormous expansion of the lateral ventricle became obvious (Fig. 1H, I ). An incipient hippocampal degeneration had been observed in constitutive ClC-7-KO mice around P30 but could not be followed much further because of the early death of those animals (6). At 1.5 yr of age, the cortex and hippocampus of forebrainspecific ClC-7-KO mice had almost disappeared (Fig.  1F, I ), and semithin sections revealed a nearly complete loss of all cortical neurons in 1-yr-old forebrain-specific ClC-7-KO mice (Supplemental Fig. 4 ). The progressive degeneration of the hippocampus was followed by hematoxylin-eosin staining ( Fig. 1J -O). Consistent with our previous results (6), neurodegeneration started in the CA3 region of the hippocampus, which showed severe neuronal cell loss as early as 30 d after birth (Fig.  1J , M). In 20-wk-old KO mice, the dentate gyrus showed conspicuous degeneration (Fig. 1K, N) , and at 1.5 yr of age, hippocampal structures were no longer detectable ( Fig. 1L , O).
Lysosomal storage disease entails region-restricted glia activation
Constitutive ClC-7-KO mice show an accumulation of electron-dense, osmiophilic lysosomal storage material in hippocampal and cortical neurons (6) . These deposits, which display typical features of NCL, became apparent at 11 d after birth and increased with age (6). Electron microscopy on forebrain-specific ClC-7-KO mice revealed that prominent storage material was distributed throughout the somata of cortical neurons at P37 ( Fig. 2A) and at the age of 8 wk (data not shown). Immunoblotting brain lysates for LC3 showed a strong increase of the LC3-II form in constitutive ClC-7-KO mice (Fig. 2B) , indicating an increase in autophagy (24) . A hallmark of NCL and of other neurodegenerative central nervous system (CNS) pathologies is astrogliosis and activation of microglia. Both features were observed in constitutive Clcn7 Ϫ/Ϫ mice (6) . We now show that these pathological changes are restricted to regions displaying lysosomal storage and neurodegeneration (Fig. 3) . In forebrain-specific ClC-7-KO mice, astrogliosis and microglia activation appeared at first in the region of the hippocampus (Fig. 3A) from where it then spread over the cortex (Fig. 3B and Supplemental  Fig. 5A, B) . Immunofluorescence staining shows that activated, enlarged microglia express ClC-7 (Fig. 3B) . Differences in the depicted microglia morphology between forebrain-specific and complete ClC-7-KO mice ClC-7-KO mice also displayed changed intraneuronal distribution of lamp-1, a marker of late endosomes and lysosomes (6) . Constitutive and forebrain-specific ClC-7-KO mice showed a more diffuse and more intense staining in hippocampal (Supplemental Fig. 6 ) and cortical ( Fig. 2C) neurons when compared to the punctate pattern in control (Clcn7 lox/lox ) mice of the same age (P38).
Endosomal and lysosomal compartments in ClC-7-KO kidney cells
To understand processes underlying the lysosomal dysfunction of ClC-7-deficient cells more thoroughly, we investigated renal PTCs. These cells take up large amounts of protein, which is destined for lysosomal degradation. Considerable amounts of lysosomal storage material accumulate in renal PTCs of Clcn7 Ϫ/Ϫ and Ostm1 Ϫ/Ϫ mice (6, 8) and, as observed in the brain (Fig. 2B) , kidney tissue displayed increased amounts of the autophagy marker LC3-II (Supplemental Fig. 7A ).
ClC-7 is strongly expressed in the kidney (1). To investigate the renal expression pattern of ClC-7 more precisely, we made use of mice that express a ClC-7/ lacZ fusion protein (7) . Analysis of X-Gal-stained kidneys from these mice revealed a broad expression of ClC-7 in all parts of the kidney (Supplemental Fig. 7B ). Immunohistochemistry of WT renal cortex (Fig. 4A) revealed that ClC-7 is most strongly expressed in PTCs, which were identified by costaining for the brushborder protein villin. Prominent staining for ClC-7 was also detected in other nephron segments, such as the cortical collecting duct and thick ascending limb (both identified by the presence of barttin; ref. 25) , as well as in podocytes of glomeruli. In the PTCs, we compared the subcellular localization of ClC-7 to those of ClC-3 and ClC-5, both of which are expressed in this nephron segment and which reside on distinct endosomal compartments (14, 21, 22, 26) . When investigated by immunofluorescence, neither protein showed a significant overlap with ClC-7 (Fig. 4B, C) . In contrast to ClC-7-positive late endosomes/lysosomes, endosomes containing ClC-5 or ClC-3 are located more apically, in closer proximity to the brush border.
As in other cell types (6 -8), ClC-7 colocalizes with its ␤-subunit Ostm1 (Supplemental Fig. 7C ) and lamp-1 (Fig. 5A) on subapical structures in PTCs. Because ClC-7 and Ostm1 are only stable when forming ClC-7/ Ostm1 heteromers (8), Ostm1 was undetectable in ClC-7-deficient PTCs (Supplemental Fig. 8B ). In PTCs of ClC-7-KO and Ostm1-deficient gray lethal mice, lamp-1-positive structures were drastically enlarged and distributed over a much broader area of the cell (Fig. 5A and Supplemental Fig. 7D ). This pattern resembles the diffuse lamp-1 pattern in Clcn7 Ϫ/Ϫ neurons ( Fig. 2C  and Supplemental Fig. 6 ). We asked whether the subcellular distribution of earlier parts of the endolysosomal pathway were altered in ClC-7-deficient PTCs and investigated the localization of ClC-5 and ClC-3. Costaining with lamp-1 on ClC-7-deficient PTCs did not reveal any major changes in morphology and distribution of either ClC-5-positive (early) or ClC-3-positive (late) endosomes (Fig. 5B, C) . Neither did we find altered expression levels of ClC-3, ClC-5, or lamp-1 in immunoblot analysis of kidney tissue (Supplemental Fig. 7E ). We next asked whether the enlarged lamp-1-positive structures in ClC-7-KO PTCs are integral parts of the endocytic system. We performed in vivo pulse-chase experiments in which we injected intravenously the lowmolecular-weight (18 kDa) protein ␤-lactoglobulin that is endocytosed from the primary urine by PTCs (11) . At 1 h after injection, fluorescently labeled ␤-lactoglobulin was found in lumina of enlarged lamp-1-positive compartments of ClC-7-deficient PTCs (Fig. 6A) , demonstrating that these structures are connected to the endocytic system. The presence of LBPA on these structures (Fig. 6B ) strongly suggests that these vesicles share features with multivesicular endosomes (23) rather than being solely of lysosomal nature.
Slower protein degradation in ClC-7-KO mice
To study the uptake and degradation of endocytosed proteins in WT and ClC-7-KO PTCs under identical conditions, we investigated PTs that contain cells expressing or lacking ClC-7 side by side. To this end, we crossed our floxed ClC-7 mouse with mice that express Cre recombinase under a renal cortex-specific ApoE promotor element, which, however, is not active in every PTC (19) .
We first examined lamp-1 expression in those chimeric tubules. Only cells lacking ClC-7, but not neighboring WT cells, displayed enlarged lamp-1-positive structures (Fig. 7A) . Hence, the enlargement of lamp-1-positive structures is a cell-autonomous effect of ClC-7 deletion. We next attempted to test whether this phenotype might be rescued by a reduction in endocytic uptake. To this end, we crossed the kidney-specific ClC-7-KO mice to ClC-5-KO mice (11), which exhibit drastically reduced endocytosis in PTCs (11, 13) . Lamp-1-positive structures appeared unaltered in PTCs lacking only ClC-5 (Supplemental Fig. 8C ). No discernible effect of ClC-5 absence on the ClC-7-KO-induced altered distribution and size of lamp-1-positive structures was observed in PTs that were chimeric for ClC-5 due to random X-chromosomal inactivation (Fig. 7B) .
After chasing endocytosed protein for 1 h into PT lysosomes of kidney-specific ClC-7-KO mice, KO cells displayed much stronger fluorescence of labeled ␤-lactoglobulin than neighboring WT cells of the same tubule ( Fig. 8A and Supplemental Fig. 8A, B) . The stronger accumulation of ␤-lactoglobulin in ClC-7-KO cells might be explained either by increased endocytosis or by impaired protein degradation. To distinguish between these possibilities, we performed pulse-chase endocytosis experiments. Fluorescence of labeled ␤-lactoglobulin was quantified for PT sections expressing or lacking ClC-7 (Fig. 8A, B) . At 10 min after injection, ␤-lactoglobulin fluorescence did not differ between WT and KO cells. Hence, ClC-7 disruption has no appre- ciable effect on apical endocytosis. At 20 min after injection, more ␤-lactoglobulin fluorescence was detected in Clcn7 Ϫ/Ϫ than WT cells of the same tubule. The same was true for 30, 40, and 60 min and 3 h (Fig.  8A, B) , strongly suggesting defective degradation of endocytosed protein in ClC-7-deficient cells. Although slowed down, lysosomal degradation was not abolished completely by the loss of ClC-7, as is evident from the reduced fluorescence after 1 h of chase (Fig. 8A) . At 24 h after injection, labeled ␤-lactoglobulin was absent from both WT and ClC-7-KO cells (data not shown).
To exclude that the longer half-life of ␤-lactoglobulin fluorescence in cells lacking ClC-7 is only due to a different handling of the fluorescent moiety, e.g., owing to slowed-down exit of the dye over the lysosomal membrane, we analyzed renal degradation of labeled ␤-lactoglobulin by SDS-PAGE (Fig. 8C) . Because of the early death of the global ClC-7-KO mice, we had to compare control with kidney-specific ClC-7-KO mice, even though this comparison would underestimate any effect because ClC-7 is only partially deleted. Lysates of chimeric ClC-7-KO and WT kidneys displayed a single fluorescent band with the size of uninjected labeled ␤-lactoglobulin at 10 min after injection ( Fig. 8C ; arrowhead), indicating that no significant lysosomal degradation of ␤-lactoglobulin had occurred yet. After 30 min, an additional band ( Fig. 8C; open arrowhead) , most likely a tagged ␤-lactoglobulin degradation product, appeared in both KO and control lysates. This band was less intense in lysates from (partial) KO kidneys. At 3 h, signals of both the undegraded protein and the degradation product were stronger in kidneyspecific ClC-7-KO than in control mice, likely because most of the ␤-lactoglobulin had been degraded in control mice by this time. A similar protein degradation defect was observed with injected albumin (data not shown) or with the fluid-phase endocytosis marker HRP (Supplemental Fig. 8D) .
We next performed endocytosis/degradation experiments in chimeric ClC-5/ClC-7 double-deficient mice. At 60 min after ␤-lactoglobulin injection, fluorescence in PTCs lacking only ClC-7 was much stronger than in ClC-7/ClC-5 double-KO cells of the same tubule (Fig. 8D) .
DISCUSSION
Progression of neurodegeneration and microglia activation
Like in the global ClC-7-KO, neurodegeneration in forebrain-specific ClC-7-KO mice began in the CA3 region of the hippocampus. It proceeded much further, as these mice have a normal life span. By the age of 1.5 yr, we found a nearly complete loss of neurons in the areas where ClC-7 was disrupted, whereas regions expressing ClC-7 were unaffected. This finding suggests that lysosomal storage and neurodegeneration depend on the absence of ClC-7 in a cell-autonomous manner, as we have shown stringently for lysosomal storage in the kidney. Although we could not study protein degradation in the brain as we did in the kidney, the increase in LC3-II argues for an impairment of protein degradation in neurons also. As observed for other types of neuropathology as diverse as trauma, stroke, tumors, or neurodegenerative diseases (27, 28) and many forms of NCL (29) , the neurodegeneration of ClC-7-KO mice is accompanied by massive activation of microglia and astrocytes (ref. 6 and the present study).
In forebrain-specific ClC-7-KO mice, which to our knowledge represent the first conditional KO mouse model for NCL, we found that this activation was restricted to brain regions in which ClC-7 had been deleted from neurons. In the regions and at time points where forebrain-specific and global ClC-7-KO mice could be compared, no difference in lysosomal storage, neurodegeneration, or glial activation could be detected, although activated microglia in the forebrainspecific KO mice express ClC-7. This observation suggests that the disruption of ClC-7 in glia does not play a major role in the CNS pathology of Clcn7 Ϫ/Ϫ mice. It does not rule out, however, that activation of microglia contributes to the observed CNS pathology.
Renal PTs as model system
In PTCs of the kidney, different endolysosomal compartments are spatially segregated, with early endosomes localized close to the apical membrane, providing favorable conditions for studying the transport and processing of endocytosed protein. Moreover, these cells display particularly high endocytotic activity, which serves to recover protein-bound vitamins from the glomerular filtrate (30) . By vascular perfusion, endocytotic substrate can be administered rapidly to the apical membrane of PTCs. This allows for unique in vivo pulse-chase experiments of endocytosis (11) . Endocytosis can be compared quantitatively between genotypes by studying chimeric tubules in which WT and KO cells lie side by side. The X-chromosomal localization of the Clcn5 gene allowed the generation of chimeric tubules simply by generating heterozygous females (11) . We here exploited the incomplete deletion of ClC-7 in crosses of floxed mice with ApoE-cre mice (19) . These kidney-specific ClC-7-KO mice also facilitate endocytosis experiments because they can be performed with adult animals. Our choice of the PT as model system is underpinned by the observation of lysosomal storage material in PTCs of Clcn7 Ϫ/Ϫ or Ostm1 Ϫ/Ϫ (gray lethal) mice (6, 8) . Analysis of PTs from these mice gave three important results: 1) The accumulation of storage material and the generation of abnormally large vesicular structures are cell-intrinsic, occurring only in cells lacking ClC-7; 2) apical endocytotic uptake of protein does not depend appreciably on ClC-7; and 3) ClC-7 disruption drastically slows, but does not abolish, proteolysis of endocytosed protein.
A possibly direct effect of ion composition on protein degradation
Lysosomal protein degradation depends on the activity of acidic hydrolases. The loss of certain lysosomal enzyme activities underlies several different forms of lysosomal storage disease (31) . In analogy to the role of ClC-3 and ClC-5 in acidifying endosomes (21, 32) and of ClC-7 in acidifying the resorption lacuna of osteoclasts (7), ClC-7 is believed to help in late endosomal/ lysosomal acidification by shunting electric currents of the H ϩ -ATPase (2, 7). Thus, slower protein degradation in ClC-7-KO cells might reflect a lowered activity of acidic hydrolases caused by an elevated luminal pH. During the transport to lysosomes, prelysosomal compartments might be acidified at a slower rate. Steadystate lysosomal pH of cultured neurons or fibroblasts derived from WT, Clcn7 Ϫ/Ϫ , or Ostm1 Ϫ/Ϫ mice, however, was undistinguishable by ratiometric fluorescence measurement (6, 8) . By contrast, a recent report asserted that lysosomal pH of HeLa cells became more alkaline when ClC-7 was partially knocked down (9) . However, that study used only single antisense and control siRNAs to manipulate ClC-7 levels. Disconcertingly, lysosomal pH reportedly was more acidic with the negative control than in untreated cells. Moreover, that study used nonratiometric measurements of total lysotracker fluorescence, which is not only a function of vesicular pH, but also of the number and volumes of vesicles. These latter parameters were not determined (9) .
In addition to luminal pH, lysosomal chloride concentration might influence lysosomal protein degradation (2, 33, 34) . For instance, there might be (so far unknown) chloride-coupled transporters for degradation products in lysosomal membranes. Chloride may also influence the activity of degradation enzymes, as shown for the lysosomal protease cathepsin C (33) . Like other vesicular CLCs (4, 5), ClC-7 has been suggested to function as a Cl Ϫ /H ϩ exchanger (2, 9), with a likely stoichiometry of 2Cl
ϩ . The large inside-out H ϩ gradient across lysosomal membranes predicts a steady-state lysosomal Cl Ϫ accumulation that would be reduced in ClC-7-KO cells even in the presence of unchanged lysosomal pH. Likewise, AtClC-a accumulates nitrate, an important plant nutrient, in vacuoles of Arabidopsis thaliana (35) . Impaired protein degradation, whether owed to changed chloride or pH in (or on the way to) lysosomes, might lead to the observed enlarged lamp1-positive structures.
Trafficking defect upon ClC-7 deficiency
To investigate whether the generation of large lamp-1-positive vesicles in Clcn7 Ϫ/Ϫ cells depends on the accumulation of undegraded endocytic cargo, we studied PTCs lacking both ClC-7 and ClC-5. Despite the strong impairment of endocytosis caused by ClC-5 disruption (11, 13, 36) , similar enlarged vesicles were observed in double-KO cells. ClC-5, however, is not only crucial for the lysosomal delivery of substrate for degradation, but also of lysosomal degradative enzymes (37) . Therefore, the additional loss of ClC-5 may further impair lysosomal degradation in Clcn7 Ϫ/Ϫ cells, rendering predictions on cargo accumulation difficult. Our in vivo endocytosis/degradation assay shows that after a 1 h chase, ClC-5/ClC-7 double-KO cells contained much less tagged protein than Clcn7 Ϫ/Ϫ cells, with fluorescence levels being similar to WT. We conclude that the accumulation of undegraded cargo is unlikely to be a major factor in the generation of those abnormal vesicles.
Although endocytosed protein reached those lamp-1-positive structures after a 1-h chase, those enlarged vesicles do not necessarily represent lysosomes, since lamp-1 is also present on late endosomes. Indeed, those vesicles were also positive for LBPA, a lipid enriched in multivesicular endosomes (23) . This observation suggests a vesicular trafficking defect, which could also affect the delivery of degradative enzymes. PTCs may be particularly vulnerable in this respect, because of a prominent role of apical endocytosis in delivering certain proteolytic enzymes to lysosomes (37) . This difference in lysosomal enzyme trafficking might explain the apparent discrepancy between the present observation of impaired proteolysis and our previous finding that the activity of the lysosomal enzyme TPP I was normal in cultured Clcn7 Ϫ/Ϫ neurons and fibroblasts (6) . Alternatively, TPP I plays no important role in the degradative pathways observed here.
A vesicular trafficking defect might also resolve the conundrum that the KO of ClC-7 abolished the acidification of the osteoclast resorption lacuna (7) but did not change lysosomal steady-state pH (6, 8) . Indeed, the acid-secreting ruffled border membrane of osteoclasts, which is formed by the exocytotic insertion of lysosomal membranes, was underdeveloped in Clcn7 Ϫ/Ϫ mice (7). Similar to the role of ClC-5 in renal endocytosis (11, 36) , the loss of ClC-7 might affect intracellular trafficking by a reduced acidification rate of late endosomes. The recruitment of some components of the vesicular transport machinery is pH-sensitive (38 -40) , and transport between various compartments of the endocytic pathway depends on vesicular H ϩ -ATPase activity (41, 42) . So far, no role of chloride in membrane trafficking is known apart from its indirect role in supporting vesicular acidification. However, novel roles of vesicular chloride are emerging. For instance, a recent report described the regulation of an early endosomal Ca 2ϩ channel by luminal [Cl Ϫ ] (43). Some evidence indicates that the release of vesicular Ca 2ϩ affects vesicle fusion and trafficking (44) .
Relationship to other CLCs
The existence of 5 distinct vesicular CLC proteins in the endosomal-lysosomal pathway (ClC-3 through ClC-7) raises the possibility of a partial compensation of the loss of ClC-7 by other CLCs. Although the localization of different vesicular CLC transporters has been studied by immunocytochemistry in transfected cells (26) and by subcellular fractionation of native tissues (6) , no costaining of different endogenous intracellular CLC proteins has been available. Our results show that the majority of ClC-5-or ClC-3-positive endosomes is distinct from ClC-7-positive late endosomes/lysosomes, agreeing with their localization to earlier endocytotic compartments (2) . We have observed previously that a proportion of ClC-3 and ClC-6 moved toward denser, lysosome-containing fractions in brain lysates of ClC-7-KO mice (45) . We have found in this work that the expression level and distribution of ClC-5 was unchanged by the loss of ClC-7 and that enlarged lamp-1-positive late endosomes/lysosomes of ClC-7-KO PTCs did not stain for ClC-5. Both in WT and in ClC-7-KO mice, we found a minor overlap of ClC-3 staining with lamp-1, as shown previously on "normal" lamp-1-positive structures in transfected cells (14) . The localization of ClC-3, which showed unaltered expression levels, seemed to be largely unchanged by ClC-7 disruption. The only other late endosomal CLC protein, ClC-6, is not expressed in the kidney (45) . Therefore, a major compensatory effect of ClC-5 or ClC-3 on lysosomal protein degradation in ClC-7-KO PTCs can be excluded.
CONCLUSIONS
Using a novel floxed ClC-7 mouse model, we have demonstrated for the first time that the lysosomal chloride transporter ClC-7/Ostm1 is important for the degradation of endocytosed protein, at least in the kidney. The failure to degrade endocytosed proteins adequately may lead to the lysosomal storage disease observed in mice and humans lacking this chloride transport activity.
